251 related articles for article (PubMed ID: 28523434)
1. Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease.
Zheng X; Chen F; Zhang Q; Liu Y; You P; Sun S; Lin J; Chen N
Protein Cell; 2017 Sep; 8(9):686-695. PubMed ID: 28523434
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease.
Shao J; Jin Y; Shao C; Fan H; Wang X; Yang G
Cell Mol Biol Lett; 2021 Aug; 26(1):36. PubMed ID: 34376139
[TBL] [Abstract][Full Text] [Related]
3. Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review.
Nijakowski K; Surdacka A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050496
[TBL] [Abstract][Full Text] [Related]
4. Analysis of salivary exosomal proteins in young adults with severe periodontitis.
Huang X; Hu X; Zhao M; Zhang Q
Oral Dis; 2020 Jan; 26(1):173-181. PubMed ID: 31630466
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
6. Salivary Stress/Immunological Markers in Crohn's Disease and Ulcerative Colitis.
Finamore A; Peluso I; Cauli O
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202858
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
Vitale S; Strisciuglio C; Pisapia L; Miele E; Barba P; Vitale A; Cenni S; Bassi V; Maglio M; Del Pozzo G; Troncone R; Staiano A; Gianfrani C
PLoS One; 2017; 12(8):e0182313. PubMed ID: 28797042
[TBL] [Abstract][Full Text] [Related]
8. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
9. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
10. Gene expression alterations in inflamed and unaffected colon mucosa from patients with mild inflammatory bowel disease.
Xu L; Ma L; Lian J; Yang J; Chen S
Mol Med Rep; 2016 Mar; 13(3):2729-35. PubMed ID: 26861951
[TBL] [Abstract][Full Text] [Related]
11. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.
Thorsvik S; Damås JK; Granlund AV; Flo TH; Bergh K; Østvik AE; Sandvik AK
J Gastroenterol Hepatol; 2017 Jan; 32(1):128-135. PubMed ID: 27640344
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease - glycomics perspective.
Hanić M; Trbojević-Akmačić I; Lauc G
Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1595-1601. PubMed ID: 31276732
[TBL] [Abstract][Full Text] [Related]
13. Exosome-Induced Regulation in Inflammatory Bowel Disease.
Zhang H; Wang L; Li C; Yu Y; Yi Y; Wang J; Chen D
Front Immunol; 2019; 10():1464. PubMed ID: 31316512
[TBL] [Abstract][Full Text] [Related]
14. [Follow-up of pediatric inflammatory bowel disease].
Guan DX; Qiu XH; Ding ZL; Wang DY; Xu XW
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(28):1984-7. PubMed ID: 22944275
[TBL] [Abstract][Full Text] [Related]
15. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
[TBL] [Abstract][Full Text] [Related]
16. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
17. Cytokines in inflammatory bowel disease.
Kmieć Z
Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of two types of exosomes in human whole saliva.
Ogawa Y; Miura Y; Harazono A; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamaguchi T; Toda T; Endo T; Tsubuki M; Yanoshita R
Biol Pharm Bull; 2011; 34(1):13-23. PubMed ID: 21212511
[TBL] [Abstract][Full Text] [Related]
19. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K
Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
Wilson A; Teft WA; Morse BL; Choi YH; Woolsey S; DeGorter MK; Hegele RA; Tirona RG; Kim RB
Dig Dis Sci; 2015 Dec; 60(12):3620-30. PubMed ID: 26160437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
